Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Rendeiro AF, Casano J, Vorkas CKyriakos, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K et al.. 2021. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.. Life Sci Alliance. 4(2) Read more about Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Google Scholar
In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery. Cacciapuoti MTeresa, Cappelli LVincenzo, Fiore D, Toruno P, Kayembe C, Tam W, Inghirami G. 2021. In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery.. Curr Protoc. 1(4):e96. Read more about In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery. Google Scholar
Corrigendum to: Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis. Plotz B, Castillo R, Melamed J, Nuovo G, Magro C, Rosenthal P, H Belmont M. 2021. Corrigendum to: Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis.. Rheumatology (Oxford). 60(7):3485. Read more about Corrigendum to: Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis. Google Scholar
Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis. Plotz B, Castillo R, Melamed J, Magro C, Rosenthal P, H Belmont M. 2021. Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis.. Rheumatology (Oxford). 60(2):e61-e63. Read more about Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis. Google Scholar
Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19. Droesch C, Do MHoang, DeSancho M, Lee E-J, Magro C, Harp J. 2020. Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19.. JAMA Dermatol. 156(9):1-3. Read more about Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19. Google Scholar
Analysis of complement deposition and viral RNA in placentas of COVID-19 patients. J Mulvey J, Magro CM, Ma LX, Nuovo GJ, Baergen RN. 2020. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients.. Ann Diagn Pathol. 46:151530. Read more about Analysis of complement deposition and viral RNA in placentas of COVID-19 patients. Google Scholar
A Covid-19 Patient with Complement-Mediated Coagulopathy and Severe Thrombosis. Showers CR, Nuovo GJ, Lakhanpal A, Siegel CH, Aizer J, Elreda L, Halevi A, Lai AR, Erkan D, Magro CM. 2021. A Covid-19 Patient with Complement-Mediated Coagulopathy and Severe Thrombosis.. Pathobiology. 88(1):28-36. Read more about A Covid-19 Patient with Complement-Mediated Coagulopathy and Severe Thrombosis. Google Scholar
WITHDRAWN: A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients. J Mulvey J, Magro CM, Ma LX, Nuovo GJ, Baergen RN. 2020. WITHDRAWN: A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients.. Ann Diagn Pathol. 46:151529. Read more about WITHDRAWN: A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients. Google Scholar
The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Magro CM, Mulvey JJ, Laurence J, Sanders S, Crowson AN, Grossman M, Harp J, Nuovo G. 2021. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.. Br J Dermatol. 184(1):141-150. Read more about The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Google Scholar
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Laurence J, J Mulvey J, Seshadri M, Racanelli A, Harp J, Schenck EJ, Zappetti D, Horn EM, Magro CM. 2020. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.. Clin Immunol. 219:108555. Read more about Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Google Scholar